Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic
Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic
Array
Activity Info
Upon completion of the activity, participants should be able to explain the circumstances – and rationale – under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar.
2. Explain the circumstances under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar